|
Par Pharmaceutical Companies is your insurance company's resource for cheaper drugs. The company markets about 70 generic drugs in more than 240 dosages; its generic product line focuses on central nervous system, cardiovascular, and anti-inflammatory medications, as well as infectious disease. Par manufactures some of its own products, but in many cases it distributes drugs manufactured by strategic partners. The company is moving into the branded pharmaceutical market as well by developing updated versions of off-patent drugs. Its first marketed brand-name product, Megace ES, treats anorexia and severe weight loss associated with AIDS; the drug is a version of a compound owned by Bristol-Myers Squibb.
|
| | | Contact Information | |
Address: |
300 Tice Blvd.
Woodcliff Lake, NJ 07677
| | Phone: | 201-802-4000 | | Fax: | 201-802-4600 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 578.10 M | | Revenue Growth (1 yr): | (-24.90%) | | Employees (2008): | 654 | | Employee Growth (1 yr): | (-8.70%) |
|
|
Key People
| | • |
Chairman, President, and CEO:
Patrick G. (Pat) LePore
| | • |
EVP and CFO:
Lawrence A. (Larry) Kenyon
| | • |
Senior Director Investor Relations and Corporate Affairs:
Allison Wey
|
|
|
